John Sarno's Healing Back Pain has inspired devotion bordering on the religious. A Seattle group dedicated to repetitive strain injuries reportedly disbanded after reading it and concluding their pain ...

SOLIS trial demonstrates that spinal cord stimulation (SCS) provides superior, sustained pain relief, function, and quality of life in nonsurgical refractory back pain.

Neuropathic pain is highly prevalent after spinal cord injury, with prevalence unrelated to severity of injury.

Aclarion, Inc. (($ACON)) announced an update on their ongoing clinical study. Aclarion, Inc. is conducting a multi-center randomized clinical ...

Millions of Americans use weed to treat chronic pain, but there's little high quality research on whether it works. New ...

Why are we asking for donations? Why are we asking for donations? This site is free thanks to our community of supporters. Voluntary donations from readers like you keep our news accessible for ...

Tiger Woods has gone through a seventh back surgery, this time to replace a disk in his lower back and had caused pain and mobility issues. Woods said in a social media post he had the surgery in New ...

Tyrone Tracy will make his return for the Giants Thursday night after missing only two games with a partially dislocated shoulder. Tracy was not on the injury report released Wednesday by the team, ...

If you were considering the purchase of a Synology NAS but were leery of the unreasonably high cost of populating it with special Synology-branded hard disk drives, you can breathe a little easier ...

This story is sponsored by TaylorMed MRI. Back pain is one of the most common health complaints in the U.S. According to research from PubMed Central, lower back pain affects about 84% of people at ...

The Internal Revenue Service, like many agencies around government, has weathered the shutdown by using existing funds to keep employees on the job. By Wednesday morning, however, those funds had run ...

CVS Health, Humana, and UnitedHealth Group have announced that they will pull back on Medicare Advantage (MA) and Part D prescription drug plans next year. These changes are a response to financial ...